Assessing the impact of positive cultures in preservation fluid on renal transplant outcomes: a scoping review
- PMID: 38869823
- DOI: 10.1007/s40620-024-01972-1
Assessing the impact of positive cultures in preservation fluid on renal transplant outcomes: a scoping review
Abstract
Background: Infection following kidney transplantation is a significant risk factor for adverse outcomes. While the donor may be a source of infection, microbiological assessment of the preservation fluid (PF) can mitigate potential recipient contamination and help curb unnecessary antibiotic use. This scoping review aimed to describe the available literature on the association between culture-positive preservation fluid, its clinically relevant outcomes, and management.
Methods: Following the Joanna Briggs Institute's scoping review recommendations, a comprehensive search in databases (EMBASE, MEDLINE, and gray literature) was conducted, with data independently extracted by two researchers from selected studies.
Results: We analysed 24 articles involving 12,052 samples, predominantly published post-2000, 91% of which retrospective. The prevalence of culture-positive preservation fluid varied from 0.86 to 77.8%. Coagulase-negative staphylococci emerged as the most frequently isolated pathogen in 14 studies. The presence of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), observed in two studies involving 1074 donors, was significantly associated with an increased risk of probable donor-derived infections (p-DDI). Of the reviewed articles, 14 reported on probable donor-derived infections, while 19 addressed the topic of preemptive antibiotic therapy.
Conclusions: Routine culturing of preservation fluid is crucial for the identification of pathogenic organisms, facilitates targeted treatment and prevents probable donor-derived infections. Furthermore, this approach helps avoid the treatment of low-virulence contaminants, thereby reducing unnecessary antimicrobial use and the risk of antibiotic resistance. In cases where ESKAPE or Candida species are detected, preemptive therapy appears to be an important strategy. Given that the current evidence primarily stems from retrospective studies, there is a pressing need for large-scale, prospective trials to corroborate these recommendations. This scoping review currently represents the most thorough compilation of evidence on how contamination of preservation fluids affects kidney transplant management.
Keywords: Infection; Kidney transplant; Preemptive treatment; Preservation fluid.
© 2024. The Author(s) under exclusive licence to Italian Society of Nephrology.
Conflict of interest statement
Declarations. Conflict of interest: The autors of this submission have no conflict of interest or financial ties to disclose. Ethical approval: The study was carried out in accordance with the Declaration of Helsinki in human research. Human and animal rights: This study does not contain animal studies performed by any of the authors. Informed consent: Informed Consent is not required for this type of study.
Similar articles
-
Incidence, distribution and clinical relevance of microbial contamination of preservation solution in deceased kidney transplant recipients: a retrospective cohort study from China.Clin Microbiol Infect. 2019 May;25(5):595-600. doi: 10.1016/j.cmi.2018.12.040. Epub 2019 Jan 16. Clin Microbiol Infect. 2019. PMID: 30659919
-
Effect of preservation fluid contamination and associated possible donor-derived infections on early postoperative prognosis in kidney transplant recipients.BMC Microbiol. 2024 May 30;24(1):189. doi: 10.1186/s12866-024-03343-z. BMC Microbiol. 2024. PMID: 38811884 Free PMC article.
-
Microbiological epidemiology of preservation fluids in transplanted kidney: a nationwide retrospective observational study.Clin Microbiol Infect. 2020 Apr;26(4):475-484. doi: 10.1016/j.cmi.2019.07.018. Epub 2019 Aug 2. Clin Microbiol Infect. 2020. PMID: 31382016
-
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review.Antimicrob Resist Infect Control. 2019 Aug 13;8:137. doi: 10.1186/s13756-019-0590-7. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31417673 Free PMC article.
-
Contamination of the Preservation Solution in Solid Organ Transplantation.Transplant Proc. 2019 Mar;51(2):392-395. doi: 10.1016/j.transproceed.2019.01.070. Epub 2019 Jan 29. Transplant Proc. 2019. PMID: 30879550 Review.
Cited by
-
Clinical Characteristics, Virulence Profile, and Molecular Epidemiology of Klebsiella pneumoniae Infections in Kidney Transplant Recipients.Infect Drug Resist. 2025 Mar 6;18:1303-1311. doi: 10.2147/IDR.S506794. eCollection 2025. Infect Drug Resist. 2025. PMID: 40065763 Free PMC article.
References
-
- Krawczyk M (2012) Incidence, pattern and clinical relevance of microbial contamination of preservation fluid in liver transplantation. Ann Transplant 17(3): 20–28. http://www.annalsoftransplantation.com/abstract/index/idArt/883454
-
- Ison MG, Grossi PASTIDCoP (2013) Donor-derived infections in solid organ transplantation: donor-derived infections in solid organ transplantation. Am J Transplant 13(s4): 22–30. https://doi.org/10.1111/ajt.12095
-
- Chang FY, Singh N, Gayowski T et al (1998) Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis 26(1): 59–65. http://www.ncbi.nlm.nih.gov/pubmed/9455510
-
- Sawyer RG, Crabtree TD, Gleason TG et al (1999) Impact of solid organ transplantation and immunosuppression on fever, leukocytosis, and physiologic response during bacterial and fungal infections. Clin Transplant 13(3): 260–265. http://www.ncbi.nlm.nih.gov/pubmed/10383107
-
- Ison MG, Nalesnik MA (2011) An update on donor-derived disease transmission in organ transplantation: donor-derived disease transmission. Am J Transplant 11(6): 1123–1130. https://doi.org/10.1111/j.1600-6143.2011.03493.x
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
